Advanced Cell Technology is a biotech company that specializes in cellular technology in the field of regenerative medicine. The company has three cellular product platforms based on its stem cell technology: Retinal Pigment Epithelial (RPE) therapy for degenerative retinal disease; Mesenchymal Stem Cells (MSCs) from renewable pluripotent stem cell sources; and the Hemangioblast (HG) platform for the treatment of blood and cardiovascular diseases. For more information visit the company’s Web site at: www.advancedcell.com.

Aegis Capital Corp. is a full service retail and institutional broker-dealer located in New York City. Aegis Capital’s management is committed to providing the highest level of service to its clients. The firm realizes this goal by running an independent, conflict-free platform that is focused on enhancing the goals of clients by bringing unencumbered advice, which enables them to freely create a plan centered on each client. For more information on Aegis Capital, visit www.aegiscapcorp.com.

Let us hear your thoughts below: